Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exosomes for Hairloss Treatment
NCT06932393Phase 1Terminated
- Sponsor
- Guangzhou Bio-gene Technology Co., Ltd.
- Start
- Apr 2025
- Primary completion
- Apr 2026
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of endothelial progenitor cell-derived exosomes in alopecia (2 arms), sponsored by Guangzhou Bio-gene Technology Co., Ltd. Primary endpoints: Comparison of localized hair density at 3 months, Safety Assessment and 1 more. Started Apr 2025; status: terminated.
02
Drugs
endothelial progenitor cell-derived exosomes
03
Conditions
alopecia
Beyond the preview
Go deeper on NCT06932393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06932393.